R.PR
REGISTERED-PRINCIPAL REGISTER
28/04/2026
Voltar para busca
Dado oficial do USPTO
WHEELER BIO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
WHEELER BIO
ST13
US500000099256856Classe
35, 39, 40, 42
Pedido
99256856
Registro
8228043
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
15
Atualização mais recente
28/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 39, 40, 42
Data de depósito
27/06/2025
Data de registro
28/04/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
28/04/2026
Última transação
28/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Primeiro uso
2022-08-00
Primeiro uso no comércio
2023-05-00
Código do desenho
4
Tipo de titular
03
Localização do titular
Oklahoma City, OK, US
Examinador
KEATING, MICHAEL P
Unidade examinadora
L10
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Wheeler Bio, Inc.
Representantes
Ava R. Shelby Wilson Sonsini Goodrich & Rosati
Classificação técnica
Classes Nice
Classe 35Classe 39Classe 40Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Business consulting services relating to product distributionoperations management serviceslogisticsreverse logisticssupply chainproduction systems and distribution solutions; Business management servicesmanaging logisticsreverse logisticssupply chain servicessupply chain visibility and synchronizationsupply and demand forecasting and product distribution processes for others; business consulting services in the field of commercialization of pharmaceutical products; distributorship services in the field of pharmaceuticalsbiopharmaceuticalshealth care products and medical products; Invoicing services; Order fulfillment services; customer services in the nature of responding to customer inquiries for others in the field of pharmaceutical product distribution and logistics; inventory control servicescomputerized business record management of pharmaceutical business data; inventory management in the field of pharmaceuticals and pharmaceutical products; computerized tracking and tracing of packages in transit for business purposes; electronic customer ordering services for pharmaceuticalspharmaceutical productsmedical products and equipmentlaboratory supplies and equipment
Classe 39
Warehousing servicesstoragedistributionpick-uppackingshipping of pharmaceuticalsbiopharmaceuticalspharmaceutical productshealth care products and medical products; supply chainlogistics and reverse logistics servicesstoragetransportation and delivery of pharmaceuticals and pharmaceutical products for others by airrailshiptruck; packaging of clinicalpharmaceutical and health care products to the order and specification of others
Classe 40
Manufacture of pharmaceuticals and biopharmaceuticals to the order and specification of others; biomanufacturing for othersmanufacturing of biological products using biological organisms in the manufacturing process for the purpose of facilitating drug development; manufacturing services for others in the fields of mammalian cell line development and therapeutic antibody development; Manufacturing process consulting; contract manufacturing services of biopharmaceuticalsantibodies and recombinant proteins utilizing mammalian cell culture to the order and specification of others; manufacturing services for others in a cGMP (Current Good Manufacturing Practice) compliant facility in the field of pharmaceutical and biopharmaceutical drug development
Classe 42
Pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical research and development; development of pharmaceuticalsbiopharmaceuticalspharmaceutical preparationsmedicinespharmaceutical packaging and drug delivery technologies; research and development of new products for others; product development consultation; product research servicesproviding analytical testingbiosafety testingreporting and laboratory services for others; scientific and technical consulting and research services in the field of pharmaceuticals; consultation in the field of pharmaceutical drug delivery and dosage technologies; custom design and development of chemical reagents and biochemical assays; Biotechnology research; Chemical research; research and development services in the field of antibodies being antibody technology; biotechnology research and development services for othersmammalian cell line development and therapeutic antibody development; development and analysis services relating to the use of mammalian cell cultures in the field of biotechnology; providing medical and scientific technology research information in the field of pharmaceuticals and biopharmaceuticalsincluding discoverypreclinicalclinical drug research and development; toxicological safety testing services for pharmaceuticals and biopharmaceuticals; pharmaceutical contract development in a cGMP (Current Good Manufacturing Practice) compliant facility in the field of pharmaceutical and biopharmaceutical drug development; laboratory testing services in clinical research and clinical trials of innovator medicines in the pharmaceutical and biotechnology fields; ChemistryManufacturingControls (CMC) laboratory and stability testing and analytical services in the fields of pharmaceutical and biopharmaceutical drug development; analytical servicesproviding Good Laboratory Practices (GLP) testing and quality assurance services to assess clinical performance in the field of pharmaceutical and biopharmaceutical drug evaluation and development
Publicações
Histórico de despachos e eventos da marca no USPTO.
15 publicações encontradas
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/03/2026
PUBO
PUBLISHED FOR OPPOSITION
10/03/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/03/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/02/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/02/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/02/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/02/2026
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
18/11/2025
GNRT
NON-FINAL ACTION E-MAILED
18/11/2025
CNRT
NON-FINAL ACTION WRITTEN
18/11/2025
DOCK
ASSIGNED TO EXAMINER
17/11/2025
MAFR
APPLICATION FILING RECEIPT MAILED
27/06/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
27/06/2025
NWAP
NEW APPLICATION ENTERED
27/06/2025
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace WHEELER BIO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.